join the leaders in advanced anti-aging medicine

More than 50 million Americans now suffer from one or more autoimmune illness and 80% are women. Thirty years ago, only one in 400 people developed an autoimmune illness but today, one in 12 Americans and one in nine women are diagnosed with an autoimmune illness. Currently we have 100+ autoimmune disorders all caused by the common thread of autoimmunity.

This module will focus on the adaptive immune system dysregulation and autoimmune disease, inflammaging and metaflammation and drivers of system wide inflammation. We will review a system’s biology approach to assessment and treatment of chronic inflammation that lead to a variety of clinical syndromes such as chronic fatigue, fibromyalgia, rheumatoid arthritis, lupus, and neurodegenerative disorders. Cellular and molecular biology of immunity, the cellular stress response, oxidation, genetic damage, inflammation, etiology of disease including environmental and lifestyle factors, and the risk for cancer development are also reviewed. Additionally, we will review innovative treatment options in autoimmune illness and ways to modulate inflammation with low dose naltrexone as well as other botanicals.

course learning objectives:

  • Identify the role of the adaptive immune system in autoimmune disease
  • Recognize the intracellular signaling pathways, cellular biology, and molecular biology of immunity and inflammation including the cell danger response and development of chronic inflammatory response syndrome (CIRS)
  • Mast Cell Activation Syndrome: the forgotten side of the immune system
  • Describe the important interactions of metabolic disorders as drivers of inflammation
  • Review innovation in the treatment of rheumatoid arthritis (RA), lupus and inflammatory bowel disease (IBD)
  • Review neurodegenerative disorders and ways to combat them
  • Compare integrative oncology protocols and immune nutrition support techniques
  • Describe the role of resolvins, protectins and other mediators in reversing the inflammatory cascade
  • Describe the role of gut dysregulation and its role in autoimmunity
  • Review the role of low-dose naltrexone in the treatment of autoimmune disorders.
  • Review the role of botanicals and other innovative substances in the treatment of systemic inflammation

Schedule

Autoimmune Disease: Adaptive Immune System Review
Joseph Bellanti, MD
1.5 hr
Cell Danger Response: Autoimmunity and Inflammation
Elisa Song, MD
1.5 hr
Chronic Inflammatory Response Syndrome
Andrew Heyman, MD, MHSA
0.75 hr
Transcription of Inflammation – Patient Cases
Ritchie Shoemaker, MD
1.25 hr
Metaflamation – A Systems Biology Approach
James LaValle, RPh, CCN
1.5 hr
Patient Cases – Connecting the Dots
Andrew Heyman, MD, MHSA
1.5 hr
Disorders Involving Inflammation and Natural Treatments: From COVID-19 to Autism Spectrum Disorder
Theoharis C. Theoharides, MS, MPhil, PhD, MD, FAAAAI
2 hr
Neurodegenerative Disorders and How to Combat
Terry Wahls, MD
2 hr
Cancer- Immune Dysregulation and Novel Treatment Approach
Mark Rosenberg, MD
2 hr
RA, Osteoarthritis
George Munoz, MD
2 hr
Resolving the Inflammatory Cascade
Sara Gottfried, MD
1 hr
Systemic Lupus Erythematosus (SLE)
Michelle Petri, MD, MPH
1 hr
Low Dose Naltrexone: Exciting Clinical Applications
Sahar Swidan, PharmD, BCPS, FMNM, ABAAHP
1 hr
Advanced Clinical Management of Inflammation
Sahar Swidan, PharmD, BCPS, FMNM, ABAAHP
1 hr
Immunomodulatory Peptides – The New Frontier
James LaValle, RPh, CCN
1 hr
Regenerative Therapies in Autoimmune Disorders
Sharon McQuillan, MD
1 hr
Clinical Experience in the use of Stem Cells for Autoimmune Disease
Rafael Gonzalez, PhD
1 hr
Patient Cases – Connecting All the Dots
Andrew Heyman, MD, MHSA
James LaValle, RPh, CCN
Sahar Swidan, PharmD, BCPS, FMNM, ABAAHP
1 hr

Registration

Module VII
Inflammaging and AutoImmunity: A Revolution in Assessment and Treatment
Physician
$2500
Allied Health
$2250